No Picture
Trading Ideas

Nvidia's Acquisition Of Arm Proves A Boon For Rival Chipmaker

Nvidia Corporation’s (NASDAQ: NVDA) $40 billion acquisition deal of the British semiconductor Arm Ltd. is acting as an accelerant for a smaller market rival.What Happened: Patrick Little, CEO and President of SiFive Inc. in an interview with Reuters claimed that customer interest in their technology is on the rise.Patrick was a former Qualcomm Inc. (NASDAQ: QCOM) executive and was declared the new CEO and President of SiFive on Thursday.SiFive operates in the commercial RISC-V processor business, an open-source chip technology. Reportedly, since his appointment, Little was contacted by many of the company’s customers “asking to work more closely on major …read more […]

No Picture
Trading Ideas

Tesla wins case against former employee accused of hacking, transferring data

Tesla had filed a lawsuit against Martin Tripp, who formerly worked at the Tesla Gigafactory in Nevada, in 2018 claiming that he had admitted to writing software that hacked the carmaker’s manufacturing operating system, transferring several gigabytes of its data to third parties and making false claims to the media. The U.S. district court of Nevada said in its ruling that it will grant Tesla’s motions to seal “because compelling reasons support them, and they are unopposed.” …read more […]

No Picture
Trading Ideas

Ericsson to buy wireless networking firm Cradlepoint in $1.1 bln deal

Ericsson has agreed to buy U.S.-based wireless networking company Cradlepoint in a $1.1 billion deal, the Swedish telecoms gear maker said on Friday. The deal, Ericsson’s largest in more than a decade, would give it access to tools that can connect devices using the so-called Internet of Things over a 4G or a 5G network. “We think this will give our customers a chance to generate new income sources within the enterprise segment,” Ericsson finance chief Carl Mellander told Reuters. …read more […]

No Picture
Trading Ideas

Arrowhead Hits the Bullseye in Phase 2 Study of ARO-AAT; Analyst Targets Over 90% Upside

Wednesday was a good day for investors of biotech Arrowhead Pharmaceuticals (ARWR). Shares took off to the tune of 40% following the release of positive trial data.In the Phase 2 open-label trial (AROAAT2002) assessing ARO-AAT for the rare genetic liver disease associated with alpha one antitrypsin deficiency (AATD), the treatment displayed convincing proof of a significant pharmacodynamic effect on AATD patients resulting in improvements in relevant biomarkers following 24 weeks of treatment.For H.C. Wainwright analyst Patrick Trucchio, the results are the latest addition to a pipeline “firing on all cylinders.”The previous several weeks have seen positive updates on several …read more […]

No Picture
Trading Ideas

Boeing 737 MAX safety upgrades are 'positive progress' – NTSB

The U.S. air accident investigator said on Thursday that proposed safety upgrades in the Boeing Co 737 MAX jet were “positive progress” toward meeting cockpit and systems recommendations it made after faulting Boeing and the Federal Aviation Administration last year for development flaws following fatal crashes. The comments from National Transportation Safety Board Chairman Robert Sumwalt were submitted during a 45-day public comment period for proposed 737 MAX design and operating changes laid out by the U.S. FAA last month. The 737 MAX was grounded worldwide 18-months ago after crashes killed 346 people in Ethiopia and Indonesia …read more […]

No Picture
Trading Ideas

Oil rises as Goldman predicts deficit, new storm builds in Gulf

Oil prices rose for a fourth straight day on Friday as Goldman Sachs estimated the market is in deficit and a new storm started building in the Gulf of Mexico, putting crude on track for a weekly gain of about 10%. Brent crude was up 27 cents, or 0.6%, at $43.57 a barrel by 0510 GMT, while U.S. oil futures gained 23 cents, or 0.6%, to $41.20 a barrel. Both contracts dipped at the start of the day but have risen sharply this week after Hurricane Sally cut U.S. production and OPEC and its allies laid out steps …read more […]

No Picture
Trading Ideas

Micron’s Long-Term Prospects Remain Strong, Says 5-Star Analyst

It has been a tough year for Micron (MU), as the chipmaker has been heavily affected by adverse macro conditions. Yet, one analyst thinks the current share price could offer new investors an opportunity to get into MU on the cheap. 5-star Rosenblatt analyst Hans Mosesmann rates MU shares a Buy along with a $100 price target. This figure implies a 96% upside from current levels. (To watch Mosesmann’s track record, click here)Mosesmann has longed banged the drum in Micron’s favor and looking ahead to the company’s August quarter (FQ4) earnings on September 29, Mosesmann implores investors snap up shares …read more […]

No Picture
Trading Ideas

Resurging coronavirus biggest threat to euro zone economy – economists

The resurgence in coronavirus cases is the biggest threat to the recovering euro zone economy, according to a Reuters poll of economists, who say growth and inflation are more likely to create negative surprises over the coming year than positive ones. While a strong euro zone rebound is underway as lockdown restrictions have been eased and businesses reopened, France and Spain among others in the 19-member bloc are grappling with a virus resurgence. …read more […]

No Picture
Trading Ideas

The 737 MAX Debacle Won’t Be the End of Boeing

(Bloomberg Opinion) — Is Boeing Co. capable of making commercial aircraft at all?It’s worth asking after an excoriating report by a U.S. congressional committee on the circumstances leading up to the fatal crashes of two 737 MAX planes. The accidents were “the horrific culmination of a series of faulty technical assumptions by Boeing’s engineers, a lack of transparency on the part of Boeing’s management and grossly insufficient oversight” by regulators, according to the report. Pending legislation may tighten that oversight, adding to future costs.The plane hasn’t flown in more than 18 months. Though European safety officials have finally completed testing …read more […]

No Picture
Trading Ideas

Pete Najarian Sees Unusual Options Activity In AMD, Bausch Health And Applied Materials

On CNBC’s “Fast Money Halftime Report,” Pete Najarian spoke about unusually high options activity in Advanced Micro Devices, Inc. (NASDAQ: AMD). He noticed aggressive buying in the name as traders bought around 7,400 contracts of the September $76 calls for 75 cents. Najarian followed the trade and he warned traders who want to do the same to remember that these calls expire on Friday.Najarian also noticed some activity in Bausch Health Companies Inc (NYSE: BHC). Options traders were active in the name for the second day in a row. On Wednesday, they bought 8,000 contracts of the October $18 calls …read more […]